Rajkumar Venkatramani

Summary

Affiliation: University of Southern California
Country: USA

Publications

  1. pmc A phase I study of vincristine, irinotecan, temozolomide and bevacizumab (vitb) in pediatric patients with relapsed solid tumors
    Rajkumar Venkatramani
    Division of Hematology Oncology, Children s Hospital Los Angeles, Los Angeles, California, USA
    PLoS ONE 8:e68416. 2013
  2. doi request reprint Correlation of clinical and dosimetric factors with adverse pulmonary outcomes in children after lung irradiation
    Rajkumar Venkatramani
    Division of Hematology Oncology, Children s Hospital Los Angeles, Los Angeles, California, USA
    Int J Radiat Oncol Biol Phys 86:942-8. 2013
  3. pmc Outcome of infants and young children with newly diagnosed ependymoma treated on the "Head Start" III prospective clinical trial
    Rajkumar Venkatramani
    Division of Hematology Oncology, Children s Hospital Los Angeles, Los Angeles, CA 90027, USA
    J Neurooncol 113:285-91. 2013
  4. doi request reprint Supratentorial ependymoma in children: to observe or to treat following gross total resection?
    Rajkumar Venkatramani
    Division of Hematology Oncology, Children s Hospital Los Angeles, 4650 Sunset Boulevard, Los Angeles, CA 90027, USA
    Pediatr Blood Cancer 58:380-3. 2012
  5. doi request reprint Tumor necrosis predicts survival following neo-adjuvant chemotherapy for hepatoblastoma
    Rajkumar Venkatramani
    Division of Hematology Oncology, Children s Hospital Los Angeles, Los Angeles, California 90027, USA
    Pediatr Blood Cancer 59:493-8. 2012
  6. doi request reprint Pleuropulmonary blastoma: a single-institution experience
    Rajkumar Venkatramani
    Division of Hematology Oncology, Department of Pathology and Laboratory Medicine, Children s Hospital Los Angeles, Los Angeles, CA 90027, USA
    J Pediatr Hematol Oncol 34:e182-5. 2012
  7. doi request reprint Pulmonary outcomes in patients with Hodgkin lymphoma treated with involved field radiation
    Rajkumar Venkatramani
    Division of Hematology Oncology, Children s Hospital Los Angeles, Los Angeles, California Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, California
    Pediatr Blood Cancer 61:1277-81. 2014
  8. doi request reprint Treatment of multiply relapsed wilms tumor with vincristine, irinotecan, temozolomide and bevacizumab
    Rajkumar Venkatramani
    Division of Hematology Oncology, Children s Hospital Los Angeles, Los Angeles, California Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, California
    Pediatr Blood Cancer 61:756-9. 2014
  9. doi request reprint Teratoid hepatoblastoma with abundant cholangioblastic component in a child with full trisomy 13
    Shengmei Zhou
    1 Department of Pathology and Laboratory Medicine, Children s Hospital Los Angeles, Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA
    Pediatr Dev Pathol 16:438-41. 2013
  10. pmc A phase I study of oxaliplatin and doxorubicin in pediatric patients with relapsed or refractory extracranial non-hematopoietic solid tumors
    Leo Mascarenhas
    Division of Hematology Oncology, Children s Hospital Los Angeles, Los Angeles, California 90027, USA
    Pediatr Blood Cancer 60:1103-7. 2013

Collaborators

Detail Information

Publications22

  1. pmc A phase I study of vincristine, irinotecan, temozolomide and bevacizumab (vitb) in pediatric patients with relapsed solid tumors
    Rajkumar Venkatramani
    Division of Hematology Oncology, Children s Hospital Los Angeles, Los Angeles, California, USA
    PLoS ONE 8:e68416. 2013
    ..To determine the maximum tolerated dose (MTD) and dose limiting toxicity (DLT) of irinotecan administered in combination with vincristine, temozolomide and bevacizumab in children with refractory solid tumors...
  2. doi request reprint Correlation of clinical and dosimetric factors with adverse pulmonary outcomes in children after lung irradiation
    Rajkumar Venkatramani
    Division of Hematology Oncology, Children s Hospital Los Angeles, Los Angeles, California, USA
    Int J Radiat Oncol Biol Phys 86:942-8. 2013
    ..To identify the incidence and the risk factors for pulmonary toxicity in children treated for cancer with contemporary lung irradiation...
  3. pmc Outcome of infants and young children with newly diagnosed ependymoma treated on the "Head Start" III prospective clinical trial
    Rajkumar Venkatramani
    Division of Hematology Oncology, Children s Hospital Los Angeles, Los Angeles, CA 90027, USA
    J Neurooncol 113:285-91. 2013
    ..This approach appears ineffective in children with infratentorial ependymoma in the absence of irradiation...
  4. doi request reprint Supratentorial ependymoma in children: to observe or to treat following gross total resection?
    Rajkumar Venkatramani
    Division of Hematology Oncology, Children s Hospital Los Angeles, 4650 Sunset Boulevard, Los Angeles, CA 90027, USA
    Pediatr Blood Cancer 58:380-3. 2012
    ..The role of radiation therapy in completely resected supratentorial ependymoma has been questioned over the past two decades...
  5. doi request reprint Tumor necrosis predicts survival following neo-adjuvant chemotherapy for hepatoblastoma
    Rajkumar Venkatramani
    Division of Hematology Oncology, Children s Hospital Los Angeles, Los Angeles, California 90027, USA
    Pediatr Blood Cancer 59:493-8. 2012
    ..We evaluated whether tumor necrosis following neo-adjuvant chemotherapy is prognostic for survival in hepatoblastoma (HB)...
  6. doi request reprint Pleuropulmonary blastoma: a single-institution experience
    Rajkumar Venkatramani
    Division of Hematology Oncology, Department of Pathology and Laboratory Medicine, Children s Hospital Los Angeles, Los Angeles, CA 90027, USA
    J Pediatr Hematol Oncol 34:e182-5. 2012
    ..A high index of suspicion for PPB must be maintained in all patients diagnosed with intrathoracic sarcoma in early childhood. Gross total resection is necessary for cure, and selected patients do not require radiation therapy...
  7. doi request reprint Pulmonary outcomes in patients with Hodgkin lymphoma treated with involved field radiation
    Rajkumar Venkatramani
    Division of Hematology Oncology, Children s Hospital Los Angeles, Los Angeles, California Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, California
    Pediatr Blood Cancer 61:1277-81. 2014
    ..The purpose of this study is to describe the prevalence of pulmonary complications in HL patients treated using contemporary protocols...
  8. doi request reprint Treatment of multiply relapsed wilms tumor with vincristine, irinotecan, temozolomide and bevacizumab
    Rajkumar Venkatramani
    Division of Hematology Oncology, Children s Hospital Los Angeles, Los Angeles, California Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, California
    Pediatr Blood Cancer 61:756-9. 2014
    ..Hematological toxicity and diarrhea were the main side effects. This regimen has activity in patients with multiply relapsed Wilms tumor without excessive toxicity, and should be evaluated further in this setting...
  9. doi request reprint Teratoid hepatoblastoma with abundant cholangioblastic component in a child with full trisomy 13
    Shengmei Zhou
    1 Department of Pathology and Laboratory Medicine, Children s Hospital Los Angeles, Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA
    Pediatr Dev Pathol 16:438-41. 2013
    ..Increased awareness of this entity and further molecular studies are needed for better understanding of the pathogenesis of teratoid hepatoblastoma...
  10. pmc A phase I study of oxaliplatin and doxorubicin in pediatric patients with relapsed or refractory extracranial non-hematopoietic solid tumors
    Leo Mascarenhas
    Division of Hematology Oncology, Children s Hospital Los Angeles, Los Angeles, California 90027, USA
    Pediatr Blood Cancer 60:1103-7. 2013
    ..This trial evaluated the maximum tolerated dose (MTD) and dose limiting toxicities (DLT) of oxaliplatin combined with doxorubicin in pediatric patients with recurrent solid tumors...
  11. doi request reprint High dose alkylator therapy for extracranial malignant rhabdoid tumors in children
    Rajkumar Venkatramani
    Division of Hematology, Oncology and Blood and Marrow Transplantation, Children s Hospital Los Angeles, Los Angeles, California Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, California
    Pediatr Blood Cancer 61:1357-61. 2014
    ..The kidney is the most common site. Isolated reports have shown improvements in patient survival, but no specific treatment regimen has shown efficacy over others...
  12. doi request reprint Current and future management strategies for relapsed or progressive hepatoblastoma
    Rajkumar Venkatramani
    Division of Hematology Oncology, Childrens Hospital Los Angeles, CA, USA
    Paediatr Drugs 14:221-32. 2012
    ..Gene-directed therapy and immunotherapy have shown promising results in the preclinical setting, and should be investigated as future treatment options for advanced hepatoblastoma...
  13. doi request reprint Hepatoblastoma and hypoplastic kidneys: a new association
    Randall Chan
    Division of Hematology Oncology, Children s Hospital Los Angeles, Los Angeles, California
    Pediatr Blood Cancer 61:1476-8. 2014
    ..This association is unlikely due to chance alone and chemotherapy regimens without cisplatin may be effective in treating these children...
  14. doi request reprint Inflammatory myofibroblastic tumors in childhood
    Bhakti Mehta
    1Division of Hematology Oncology, Children s Hospital Los Angeles, Los Angeles, California, USA
    Pediatr Hematol Oncol 30:640-5. 2013
    ..Severe inflammatory response and death occurred in one patient. The 3-year event free and overall survivals (OS) were 58 ± 20% and 89 ± 10% respectively. ..
  15. doi request reprint Hepatoblastoma in a patient with methylmalonic aciduria
    Randall Chan
    Division of Pediatric Hematology Oncology, Los Angeles County University of Southern California Medical Center, Los Angeles, California Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, California
    Am J Med Genet A 167:635-8. 2015
    ..He remains in remission more than five years after his transplant. In addition, his transplant has cured his MMA and he is able to tolerate a regular diet without developing metabolic crises...
  16. doi request reprint Pulmonary function abnormalities in childhood cancer survivors treated with bleomycin
    Aliva De
    Division of Pulmonology, Children s Hospital Los Angeles, Los Angeles, California
    Pediatr Blood Cancer 61:1679-84. 2014
    ..We evaluated the prevalence of long-term pulmonary function abnormalities in children receiving bleomycin therapy in the context of current chemotherapeutic regimens...
  17. doi request reprint Oxaliplatin and Doxorubicin for relapsed or refractory high-risk neuroblastoma
    Hung C Tran
    2Division of Hematology Oncology BMT, Children s Hospital Los Angeles, Los Angeles, California, USA
    Pediatr Hematol Oncol 32:26-31. 2015
    ..In our cohort of heavily pretreated relapsed and refractory neuroblastoma patients, the combination of oxaliplatin and doxorubicin demonstrated anti-tumor activity and merits further investigation...
  18. pmc Congenital abnormalities and hepatoblastoma: a report from the Children's Oncology Group (COG) and the Utah Population Database (UPDB)
    Rajkumar Venkatramani
    Division of Hematology Oncology, Children s Hospital Los Angeles, Los Angeles, California Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, California
    Am J Med Genet A 164:2250-5. 2014
    ..Consistent with the COG findings, kidney/bladder defects were associated with hepatoblastoma. These results confirm the association of HB with kidney/bladder abnormalities...
  19. doi request reprint Zoledronic Acid for the Treatment of Children With Refractory Central Giant Cell Granuloma
    May C Chien
    Keck School of Medicine, University of Southern California Division of Hematology, Oncology, and Blood and Marrow Transplantation Division of Plastic Surgery, Children s Hospital Los Angeles, Los Angeles, CA Department of Pediatrics, Texas Children s Cancer Center, Baylor College of Medicine, Houston, TX
    J Pediatr Hematol Oncol 37:e399-401. 2015
    ..We describe 4 patients with CGCG treated with ZA, 3 of whom achieved resolution of disease up to 4 years of follow-up. Our experience suggests that ZA may be considered as treatment for pediatric CGCG. ..
  20. doi request reprint Successful treatment of recurrent metastatic nasopharyngeal carcinoma with oxaliplatin and doxorubicin
    Rajkumar Venkatramani
    Division of Hematology Oncology, Children s Hospital Los Angeles Department of Pediatrics, Keck School of Medicine, University of Southern California, Los Angeles, CA
    J Pediatr Hematol Oncol 36:e307-9. 2014
    ..The patient was treated with a novel combination of oxaliplatin and doxorubicin without irradiation. ..
  21. doi request reprint Hepatoblastoma in a 15-month-old female with trisomy 13
    Rachana Shah
    Division of Hematology and Oncology, Children s Hospital Los Angeles, Los Angeles, California
    Am J Med Genet A 164:472-5. 2014
    ..This may represent a non-random association, as somatic trisomy of chromosome 13 in hepatoblastoma tumors has been previously described in the literature. Prolonged survival may have allowed for hepatoblastoma to present in our patient...
  22. doi request reprint Gorham's disease and diffuse lymphangiomatosis in children and adolescents
    Rajkumar Venkatramani
    Division of Hematology Oncology, Children s Hospital Los Angeles, Los Angeles, California 90027, USA
    Pediatr Blood Cancer 56:667-70. 2011
    ..Soft tissue lymphangioma was present in seven and six children had splenic involvement. Disease stabilization and improvement was observed on treatment with interferon alpha-2b and bisphosphonate therapy...